Lung Disease News |
New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US
Lung Disease News Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food and Drug … SPIRIVA® RESPIMAT® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents |
View full post on asthma – Google News